Patents by Inventor Kazuhiro Hosoi

Kazuhiro Hosoi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10881909
    Abstract: A non-limiting example training instrument comprises a hollow main body formed of an aluminum alloy. The main body is constituted by two gripping portions opposite to each other with a space therebetween and a coupling portion coupling the two gripping portions. A load sensor is arranged in the coupling portion inside the main body. The load sensor is a load cell, a strain gauge affixed to an interior of the main body, and a part of the main body to which the strain gauge is affixed functions as a strain body. Therefore, if a user applies a force so as to bring the two gripping portions close to each other or a force so as to move the two gripping portions away from each other, a load thereof is detected by the load sensor.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: January 5, 2021
    Assignee: Nintendo Co., Ltd.
    Inventors: Ryoji Kuroda, Shinji Yamamoto, Hiroki Ikuta, Takanori Okamura, Xiaoming Jin, Hitoshi Tsuchiya, Kazuhiro Hosoi, Satoru Osako
  • Publication number: 20200215093
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 9, 2020
    Applicant: Santen Pharmaceutical Co., Ltd.
    Inventors: Akiko Sakatani, Tatsuo Ikei, Koji Inagaki, Masatsugu Nakamura, Kazuhiro Hosoi, Mikiko Saito, Masaki Sonoda, Yoko Fukui, Mitsuaki Kuwano
  • Publication number: 20200176774
    Abstract: Provided is a magnesium secondary battery including a positive electrode member 23 including at least a positive electrode active material layer 23B, a separator 24 disposed facing the positive electrode member 23, a negative electrode member 25 containing magnesium or a magnesium compound disposed facing the separator 24, and an electrolytic solution containing a magnesium salt. The positive electrode active material layer 23B includes magnesium sulfide having a zinc blende type crystal structure.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 4, 2020
    Inventors: Kazuhiro KAMIGUCHI, Ryuhei MATSUMOTO, Kiyoshi KUMAGAE, Shizuka HOSOI, Yuri NAKAYAMA
  • Patent number: 10632139
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: April 28, 2020
    Assignee: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Akiko Sakatani, Tatsuo Ikei, Koji Inagaki, Masatsugu Nakamura, Kazuhiro Hosoi, Mikiko Saito, Masaki Sonoda, Yoko Fukui, Mitsuaki Kuwano
  • Publication number: 20200016460
    Abstract: A non-limiting example training instrument comprises a hollow main body formed of an aluminum alloy. The main body is constituted by two gripping portions opposite to each other with a space therebetween and a coupling portion coupling the two gripping portions. A load sensor is arranged in the coupling portion inside the main body. The load sensor is a load cell, a strain gauge affixed to an interior of the main body, and a part of the main body to which the strain gauge is affixed functions as a strain body. Therefore, if a user applies a force so as to bring the two gripping portions close to each other or a force so as to move the two gripping portions away from each other, a load thereof is detected by the load sensor.
    Type: Application
    Filed: September 25, 2019
    Publication date: January 16, 2020
    Inventors: Ryoji KURODA, Shinji YAMAMOTO, Hiroki IKUTA, Takanori OKAMURA, Xiaoming JIN, Hitoshi TSUCHIYA, Kazuhiro HOSOI, Satoru OSAKO
  • Publication number: 20200005913
    Abstract: An example of a display system includes a sensor, a projector, and control means. The sensor senses user information for calculating a state regarding sleep of a user. The user information is, for example, biological information such as pulse. The projector projects and displays a predetermined image. The projector, for example, projects the image upward to project and display the image on the ceiling. The control means controls the projector in accordance with a state regarding sleep, which is calculated on the basis of the user information.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 2, 2020
    Inventors: Eizi KAWAI, Masahiro KONDO, Kazuhiro HOSOI
  • Patent number: 10504616
    Abstract: An example of a display system includes a sensor, a projector, and control means. The sensor senses user information for calculating a state regarding sleep of a user. The user information is, for example, biological information such as pulse. The projector projects and displays a predetermined image. The projector, for example, projects the image upward to project and display the image on the ceiling. The control means controls the projector in accordance with a state regarding sleep, which is calculated on the basis of the user information.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: December 10, 2019
    Assignee: Nintendo Co., Ltd.
    Inventors: Eizi Kawai, Masahiro Kondo, Kazuhiro Hosoi
  • Patent number: 10471303
    Abstract: A non-limiting example training instrument comprises a hollow main body formed of an aluminum alloy. The main body is constituted by two gripping portions opposite to each other with a space therebetween and a coupling portion coupling the two gripping portions. A load sensor is arranged in the coupling portion inside the main body. The load sensor is a load cell, a strain gauge affixed to an interior of the main body, and a part of the main body to which the strain gauge is affixed functions as a strain body. Therefore, if a user applies a force so as to bring the two gripping portions close to each other or a force so as to move the two gripping portions away from each other, a load thereof is detected by the load sensor.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: November 12, 2019
    Assignee: Nintendo Co., Ltd.
    Inventors: Ryoji Kuroda, Hiroki Ikuta, Shinji Yamamoto, Takanori Okamura, Xiaoming Jin, Hitoshi Tsuchiya, Kazuhiro Hosoi, Satoru Osako
  • Patent number: 10284831
    Abstract: Provided is a projection system that sets an arbitrary three-dimensional shape as a projection target and properly corrects geometric distortion of a projected image even when a user's viewpoint is not fixed. A projection unit of the projector apparatus projects a test image for first adjustment. A three-dimensional shape measurement unit measures the three-dimensional shape of the projection target. An image capturing apparatus captures the test image for first adjustment projected by the projection unit to obtain a captured image for first adjustment.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: May 7, 2019
    Assignees: MEGACHIPS CORPORATION, NINTENDO CO., LTD.
    Inventors: Motoyasu Tanaka, Yuki Haraguchi, Fumiya Shingu, Eizi Kawai, Kazuhiro Hosoi
  • Publication number: 20180353531
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Application
    Filed: August 14, 2018
    Publication date: December 13, 2018
    Applicant: Santen Pharmaceutical Co., Ltd.
    Inventors: Akiko Sakatani, Tatsuo Ikei, Koji Inagaki, Masatsugu Nakamura, Kazuhiro Hosoi, Mikiko Saito, Masaki Sonoda, Yoko Fukui, Mitsuaki Kuwano
  • Patent number: 10071113
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: September 11, 2018
    Assignee: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Akiko Sakatani, Tatsuo Ikei, Koji Inagaki, Masatsugu Nakamura, Kazuhiro Hosoi, Mikiko Saito, Masaki Sonoda, Yoko Fukui, Mitsuaki Kuwano
  • Patent number: 9928580
    Abstract: Provided is a projection system that easily and appropriately reduces the geometric distortion of the image projected on the projection plane. The projection circuitry 3 of the projection system 1000 projects a test image onto the projection plane. The three-dimensional shape measurement circuitry 4 measures the three-dimensional shape of the projection plane. The controller 200 generates a control signal. Based on the measured three-dimensional shape data, the projection image adjustment circuitry 1 performs correction processing and rotation processing on a test, in accordance with the control signal, such that the geometrical image distortion is reduced as viewed from the user's viewpoint.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: March 27, 2018
    Assignees: MegaChips Corporation, Nintendo Co., Ltd.
    Inventors: Motoyasu Tanaka, Yuki Haraguchi, Fumiya Shingu, Eizi Kawai, Kazuhiro Hosoi
  • Publication number: 20180018761
    Abstract: Provided is a projection system that easily and appropriately reduces the geometric distortion of the image projected on the projection plane. The projection circuitry 3 of the projection system 1000 projects a test image onto the projection plane. The three-dimensional shape measurement circuitry 4 measures the three-dimensional shape of the projection plane. The controller 200 generates a control signal. Based on the measured three-dimensional shape data, the projection image adjustment circuitry 1 performs correction processing and rotation processing on a test, in accordance with the control signal, such that the geometrical image distortion is reduced as viewed from the user's viewpoint.
    Type: Application
    Filed: September 28, 2017
    Publication date: January 18, 2018
    Applicants: MegaChips Corporation, Nintendo Co., Ltd.
    Inventors: Motoyasu TANAKA, Yuki HARAGUCHI, Fumiya SHINGU, Eizi KAWAI, Kazuhiro HOSOI
  • Publication number: 20180007329
    Abstract: Provided is a projection system that sets an arbitrary three-dimensional shape as a projection target and properly corrects geometric distortion of a projected image even when a user's viewpoint is not fixed. A projection unit of the projector apparatus projects a test image for first adjustment. A three-dimensional shape measurement unit measures the three-dimensional shape of the projection target. An image capturing apparatus captures the test image for first adjustment projected by the projection unit to obtain a captured image for first adjustment.
    Type: Application
    Filed: September 18, 2017
    Publication date: January 4, 2018
    Applicants: MegaChips Corporation, Nintendo Co., Ltd.
    Inventors: Motoyasu TANAKA, Yuki HARAGUCHI, Fumiya SHINGU, Eizi KAWAI, Kazuhiro HOSOI
  • Publication number: 20170020910
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Application
    Filed: October 10, 2016
    Publication date: January 26, 2017
    Applicant: SANTEN PHARMACEUTICAL CO., LTD.
    Inventors: Akiko SAKATANI, Tatsuo IKEI, Koji INAGAKI, Masatsugu NAKAMURA, Kazuhiro HOSOI, Mikiko SAITO, Masaki SONODA, Yoko FUKUI, Mitsuaki KUWANO
  • Patent number: 9486529
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: November 8, 2016
    Assignee: SANTEN PHARMCEUTICAL CO., LTD.
    Inventors: Akiko Sakatani, Tatsuo Ikei, Koji Inagaki, Masatsugu Nakamura, Kazuhiro Hosoi, Mikiko Saito, Masaki Sonoda, Yoko Fukui, Mitsuaki Kuwano
  • Publication number: 20160317099
    Abstract: An example of a display system includes a sensor, a projector, and control means. The sensor senses user information for calculating a state regarding sleep of a user. The user information is, for example, biological information such as pulse. The projector projects and displays a predetermined image. The projector, for example, projects the image upward to project and display the image on the ceiling. The control means controls the projector in accordance with a state regarding sleep, which is calculated on the basis of the user information.
    Type: Application
    Filed: July 15, 2016
    Publication date: November 3, 2016
    Inventors: Eizi KAWAI, Masahiro KONDO, Kazuhiro HOSOI
  • Patent number: 9381428
    Abstract: An information processing apparatus is set to always obtain information, even while an application is not being executed, and effectively using the obtained information. A state of the environment in a place where the information processing apparatus is present is detected. Detection data indicating the state of the environment detected by the detection section is stored. An operation mode is switched at least between a normal mode in which power is being supplied to the application execution section and the predetermined application can be executed, and a power saving mode in which at least supply of power to the application execution section is restricted and the predetermined application cannot be executed. At least in the power saving mode, a state of the environment is detected, and detection data indicating the state of the environment detected is stored in the first storage section at predetermined time intervals.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: July 5, 2016
    Assignee: NINTENDO CO., LTD.
    Inventors: Yasuyuki Shimohata, Ryoji Kuroda, Kazuhiro Hosoi, Takanori Okamura
  • Publication number: 20150072951
    Abstract: Regarding Diquafosol ophthalmic solution comprising a chelating agent at a concentration of 0.0001 to 1% (w/v), formation of insoluble precipitates found in Diquafosol ophthalmic solution during storage of the solution, as well as deterioration of the filtration performance in the course of production (course of filtration sterilization), have been inhibited. Further, in Diquafosol ophthalmic solution comprising a chelating agent, reduction of eye irritation and enhancement of the preservative effectiveness have been confirmed, in comparison to Diquafosol ophthalmic solution comprising no chelating agent. Accordingly, the present invention has been confirmed to provide physicochemical properties that are stable during the courses of production and distribution as well as the course of storage by a patient, and also reduce eye irritation and enhance preservative effectiveness.
    Type: Application
    Filed: March 25, 2013
    Publication date: March 12, 2015
    Inventors: Akiko Sakatani, Tatsuo Ikei, Koji Inagaki, Masatsugu Nakamura, Kazuhiro Hosoi, Mikiko Saito, Masaki Sonoda, Yoko Fukui, Mitsuaki Kuwano
  • Patent number: 8870653
    Abstract: An operating device has a narrow housing, and in this housing, an acceleration sensor and/or a gyro sensor are accommodated. Operation data inclusive of acceleration data and/or angular velocity data acquired from the acceleration sensor and/or the gyro sensor is transmitted by an operation data transmitter. Then, at a lower end of the housing, an elastic member having a spherical surface or substantially a spherical surface is provided.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: October 28, 2014
    Assignee: Nintendo Co., Ltd.
    Inventors: Toru Yamashita, Yasuyuki Shimohata, Kazuhiro Hosoi, Ryoji Kuroda